Preventing infectious complications with nutrition intervention

Journal of Parenteral and Enteral Nutrition

Volumn 29, Issue SUPPL. 1, 2005, Pages

  Martindale, R G ^a   Cresci, Gail ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; GLUTAMINE; IMMUNOMODULATING AGENT; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SELENIUM;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM CANCER; ENTERIC FEEDING; HEAD AND NECK CANCER; HEART SURGERY; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; INTESTINE LYMPHATIC TISSUE; META ANALYSIS; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEPSIS;

EID: 12544256908     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/01486071050290s1s53     Document Type: Conference Paper

References (30)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
2. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis. 2004;10:1-15.
3. Moss M, Martin GS. A global perspective on the epidemiology of sepsis. Intensive Care Med. 2004;30:527-529.
4. Riedemann NC, Guo RF, Ward PA. The enigma of sepsis. J Clin Invest. 2003;112:460-467.
5. DiPiro JT, Martindale RG, Bakst A, Vacani PF, Watson P, Miller MT. Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care. Am J Health Syst Pharm. 1998; 55:777-781.
6. Stafford RE, Weigelt JA. Surgical infections in the critically ill. Curr Opin Crit Care. 2002;8:449-452.
7. Levy SB. The 2000 Garrod lecture: factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002; 49:25-30.
8. Shah AA, Hasan F, Ahmed S, Hameed A. Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection. Crit Rev Microbiol. 2004;30:25-32.
9. Chi CY, Wong WW, Fung CP, Yu KW, Liu CY. Epidemiology of community-acquired Staphylococcus aureus bacteremia. J Microbiol Immunol Infect. 2004;37:16-23.
10. Wallace WC, Cinat ME, Nastanski F, Gornick WB, Wilson SE. New epidemiology for postoperative nosocomial infections. Am Surg. 2000;66:874-878.
11. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
12. Boyce JM, Pittet D. Recommendations of the Healthcare Infection Control Practice Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline Hand Hygiene Health Care Settings. 2002;51:1-44.
13. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
14. Montori VM, Bistrian BR, McMahon MM. Hyperglycemia in acutely ill patients. JAMA. 2002;288:2167-2169.
15. Krogh-Madsen R, Moller K, Dela F, Kronborg G, Jauffred S, Pedersen BK. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-α, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab. 2004;286:E766-E772.
16. Gianotti L, Braga M, Radaelli G, Mariani L, Vignali A, Di Carlo V. Lack of improvement of prognostic performance of weight loss when combined with other nutritional parameters. Nutrition. 1995;11:12-16.
17. Mora RJF. Malnutrition: organ and functional consequences. World J Surg. 1999;23:530-535.
18. Kudsk KA, Tolley EA, DeWitt RC, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003;27:1-9.
19. Moore FA, Feliciano DV, Andrassy RJ, et al. Early enteral feeding compared with parenteral, reduces postoperative septic complications: the results of a meta-analysis. Ann Surg. 1992;216:172-183.
20. Heyland DK. Nutritional support in the critically ill patient: a critical review of the evidence. Crit Care Clin. 1998;14:423-440.
21. Jabbar A, Chang WK, Dryden GW, McClave SA. Gut immunology and the differential response to feeding and starvation. Nutr Clin Pract. 2003;18:461-482.
22. Murphy PG, Ogilvy AJ, Whiteley SM. The effect of propofol on the neutrophil respiratory burst. Eur J Anaesthesiol. 1996;13:471-473.
23. Garnacho Montero J, Shou J, Ortiz Leyba C, Jimenez Jimenez FJ, Daly JM. Lipids and immune function. Nutr Hosp. 1996;11:230-237.
24. Waitzberg DL, Lotierzo PH, Logullo AF, Torrinhas RS, Pereira CC, Meier R. Parenteral lipid emulsions and phagocytic systems. Br J Nutr. 2002;87(Suppl):S49-S57.
25. McCowen KC, Bistrian BR. Immunonutrition: problematic or problem solving? Am J Clin Nutr. 2003;77:764-770.
26. Proceedings from summit on immune-enhancing enteral therapy. JPEN J Parenter Enteral Nutr. 2001;25(Suppl):S1-S63.
27. Heys SD, Walker LG, Smith I, Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999;229:467-477.
28. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999; 27:2799-2805.
29. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-953.
30. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36:S11-S23.